Navigation Links
EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Date:8/20/2007

LYON, France, Aug. 17 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, is currently conducting clinical investigations in France under an approved clinical trial combining the company's Ablatherm-HIFU device with chemotherapy using docetaxel.

The study is a primary treatment therapy program for men suffering from clinically localized but aggressive high risk prostate cancer typically classified as stage T2c. The study began in late 2006 and will enroll a total of 30 men, of which more than 10 have already been treated.

"Combination therapy is well documented as a treatment protocol for men suffering more aggressive prostate cancers," said Dr. Albert Gelet, Edouard Herriot Hospital, Lyon. "Ablatherm-HIFU is a proven effective treatment for localized prostate cancer already with strong clinical support. This study aims to evaluate its use under an additional dedicated protocol for men in the T2c cancer stage where the tumors are known to be more aggressive, creating a higher risk of relapse if the patient is treated with only a localized therapy. It was demonstrated in pre-clinical studies that HIFU improves chemotherapy drug efficacy in the area around burned tissues."

Under the approved protocol by French Ethical Committee, patients are administered a dose of docetaxel 30 minutes prior to a standard primary indication HIFU session lasting an average of two hours. The Ablatherm-HIFU ablates the prostate tissue according to conventional procedures and protocols. All treatments are administered at Edouard Herriot Hospital in Lyon, France.

"EDAP has a strong scientific and clinical base underlying the Ablatherm-HIFU, with constant work to enhance and extend the capabilities of the device," said Pr John Rewcastle, Medical Director for EDAP. "With already well documented specialized protocols for primary therapy, HIFU retreatment and salvage th
'/>"/>

SOURCE EDAP TMS S.A.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... Massachusetts y LONDRES, August 30, 2015 /PRNewswire/ ... ofrece una visión holística de l ... todo el trayecto   ... hoy el debut europeo de IntelliSpace Cardiovascular , ... que ofrece sofisticadas herramientas para acceder, analizar y compartir ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Originally discovered by Welfide ... Pharmaceutical Industries, Ltd) as an inflammatory drug, pranoprofen ... Pharmaceutical Co., Ltd under the trade name of ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2
... NEW YORK, April 28, 2011 Reportlinker.com ... is available in its catalogue: ... Healthcare System and Drug Regulatory Overview: Cost-containment ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html ...
... 28, 2011 West Pharmaceutical Services, Inc. (NYSE: ... quarter of 2011.  Summary comparative results were as follows:($ millions, ... 295.4 , $ 274.7Gross Profit , 88.0 , 82.2Reported Operating ... 30.7 , 29.5Reported Diluted EPS , $ 0.56 , $ ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6West Announces First Quarter 2011 Results 2West Announces First Quarter 2011 Results 3West Announces First Quarter 2011 Results 4West Announces First Quarter 2011 Results 5West Announces First Quarter 2011 Results 6West Announces First Quarter 2011 Results 7West Announces First Quarter 2011 Results 8West Announces First Quarter 2011 Results 9West Announces First Quarter 2011 Results 10West Announces First Quarter 2011 Results 11West Announces First Quarter 2011 Results 12West Announces First Quarter 2011 Results 13West Announces First Quarter 2011 Results 14
(Date:8/31/2015)... ... 31, 2015 , ... CareSource, a nonprofit Ohio-based health plan, ... capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications and ... have contributed to the company’s rapid growth. As the CareSource business model expands ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Bay Pines VA Healthcare System ... southwest Florida by hiring more doctors and nurses and expanding existing facilities and services. ... In early July, Dr. Anthony Jabre was selected to lead and grow the Bay ...
(Date:8/31/2015)... , ... September 01, 2015 , ... ... Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy ”. ... breakthrough. Traumatic brain injury has been largely untreatable - with mostly palliative treatments ...
(Date:8/31/2015)... ... 2015 , ... Since 1946, the doctors and staff at Clifton Dental Associates ... patient arrives at the office, the staff will make them feel welcome and comfortable. ... to create a complete dental treatment plan that is unique to each smile! ...
(Date:8/31/2015)... ... ... LUT Soft pack from Pixel Film Studios, editors can quickly and easily add soft color ... modifying an image. The LUT changes every pixel's color to the corresponding color indicated by ... requires Final Cut Pro X 10.2 or newer. , By manipulating each pixel, LUTs ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2
... , ... amongst the first to utilize cutting edge high definition technology for patients with visual impairments. ... (PRWEB) February 3, ... of recent technological advancements in eye surgery. In addition to promising 20/20 vision, new corrective ...
... ... received approval for re-accreditation by the American College of Radiology (ACR) , ... Berkeley Heights (Vocus) February 2, ... American College of Radiology (ACR) for the period of January 2010 through January 2013. ...
... , ... cigarette brand Intellicig has signed an exclusive deal which will see their products stocked ... Distribution and Smiths News. , ... (PRWeb UK) February 2, 2010 -- Leading electronic cigarette brand Intellicig has ...
... , NEW YORK , Feb. 2 ... organization, will host its first charity fundraiser at Jonathan in ... event will launch a much needed organization whose sole purpose is ... and to administer compassionate patient counseling. , Founder Melissa A. ...
... all human embryonic stem cell lines being used in 2005 ... left traces on the human cells. If those cells had ... been rejected by the patient,s immune system. Even today, ... research, there remains a risk that these cells will be ...
... suggested one scan is usually enough, but editorial begs to ... for a paper in a medical journal to be accompanied ... paper might be "overly simple and consequently not clinically useful." ... Feb. 3 issue of the Journal of the American ...
Cached Medicine News:Health News:HD For More Than Your TV – New Technologies Offer Patients High Definition Vision At Any Age 2Health News:Nuclear Medicine at Summit Medical Group Earns ACR Re-Accreditation 2Health News:Intellicig Clinches Exclusive Deal with Retail Distribution-Giant to Distribute Their Industry Leading Electronic Cigarettes 2Health News:Intellicig Clinches Exclusive Deal with Retail Distribution-Giant to Distribute Their Industry Leading Electronic Cigarettes 3Health News:February Fundraiser Launches Cohen Esophageal Cancer Initiative (CECI) 2Health News:3-D scaffold provides clean, biodegradable structure for stem cell growth 2Health News:3-D scaffold provides clean, biodegradable structure for stem cell growth 3Health News:Analysis Examines Ultrasound Use for Blood Clots 2Health News:Analysis Examines Ultrasound Use for Blood Clots 3
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... only catheter of its kind, the ... collects real-time cardiac electrical information, translating ... With 64 electrodes, this unique tool ... than 3,000 points of electrical data ...
... The St. Jude Medical® Pacing System Analyzer ... solution for implantation testing, programming and interrogation ... as an easy-to-use accessory to the St. ... testing by obtaining measurements of intrinsic P- ...
Medicine Products: